Mitchell JL, Lyons HS, Walker JK, et al
Do the cardiovascular and renal benefits of SGLT2 inhibitors and GLP-1 receptor agonists demonstrated in patients with established CVD extend to lower-risk patients
McCune: I think people still do, but maybe for a different reason
However, if you are experiencing significant caloric restriction, you may need to temporarily reduce exercise intensity whilst your body adapts
One study showed that liraglutide reduced vascular damage, neuronal loss, and cognitive impairment in a mouse model of Alzheimer's disease
This increase in cAMP activates downstream effectors such as protein kinase A (PKA) and exchange protein directly activated by cAMP 2 (Epac2), which modulate various cellular responses [8]